Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHD.L Regulatory News (PHD)

  • There is currently no data for PHD

Directorate Change

1 Oct 2020 07:00

RNS Number : 6750A
PROACTIS Holdings PLC
01 October 2020
 

Proactis Holdings PLC

Directorate Change

 

Proactis Holdings PLC, ("Proactis", the "Group" or the "Company"), the business spend management solution provider, announces that Sean McDonough, Chief Information Officer, has today resigned from the Board with immediate effect. Sean will remain employed by the Company during his twelve-month notice period.

Alan Aubrey, Non-Executive Chairman, commented:

"On behalf of the board I would like to thank Sean for his valued contribution and service to the Company over the past 15 years. We are grateful to him for the delivery of his personal succession plan which allows the Company to move forward with confidence. We wish him all the very best in the future."

 

For further information, please contact:

Proactis Holdings PLC

Tim Sykes, Chief Executive Officer

 

01937 545070 investorcontact@proactis.com

finnCap Ltd

Carl Holmes/Emily Watts/Matthew Radley - Corporate Finance

Andrew Burdis/Richard Chambers - ECM

 

0207 220 0500

 

 

Alma PR

Rebecca Sanders-Hewett, Sam Modlin, David Ison

 

020 3405 0205

Proactis@almapr.co.uk

 

Notes to Editors:

Proactis creates, sells and maintains software and services which enable organisations to streamline, control and monitor all indirect expenditure. Its solutions are used in approximately 1,100 buying organisations around the world from the commercial, public and not-for-profit sectors.

 

Remuneration: 

Sean will continue to receive his full contractual entitlement through his notice period and an ex gratia payment of £30,000 (including statutory payments) at the end of that notice period. For the purposes of his Enterprise Management Incentive ("EMI") Scheme awards and his Executive Share Option Scheme ("ESO") awards, Sean has been classified as a good leaver. Awards granted under the Group's EMI Scheme and ESO Scheme are fully vested and remain capable of being exercised until the end of Sean's notice period after which they will lapse. Awards granted under the Long Term Incentive Plan will continue and remain capable of vesting at the normal vesting date (which occurs during his notice period) subject to the performance conditions being met.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAQBLFXBKLXBBB
Date   Source Headline
29th Apr 20217:00 amRNSInterim Results
23rd Mar 20217:00 amRNSContract Win
24th Feb 20217:01 amRNSTrading Update & Notice of Results
24th Feb 20217:00 amRNSbePayd Strategic Contract Win
10th Feb 20217:00 amRNSStrategic Contract Win
8th Jan 202111:15 amRNSHolding(s) in Company
17th Dec 20208:58 amRNSDirector/PDMR Shareholding
14th Dec 20205:19 pmRNSResult of AGM
9th Dec 20207:00 amRNSFirst bePayd contract
7th Dec 20205:00 pmRNSHolding(s) in Company
2nd Dec 20207:00 amRNSNotice of AGM
2nd Dec 20207:00 amRNSDirectorate Change
30th Nov 20207:00 amRNSStrategic Contract Win
19th Nov 20207:00 amRNSDirector/PDMR Shareholding
10th Nov 20205:21 pmRNSHolding(s) in Company
3rd Nov 20205:09 pmRNSHolding(s) in Company
29th Oct 202011:40 amRNSDirector/PDMR Shareholding
29th Oct 20207:00 amRNSFinal Results
19th Oct 20207:00 amRNSStrategic Contract Win
14th Oct 20207:00 amRNSNotice of Results
6th Oct 20205:02 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSDirectorate Change
1st Oct 20207:00 amRNSDirectorate Change
2nd Sep 20205:07 pmRNSHolding(s) in Company
25th Aug 20207:00 amRNSTrading Update
13th Jul 20205:04 pmRNSHolding(s) in Company
24th Jun 20207:00 amRNSHolding(s) in Company
16th Jun 20206:16 pmRNSHolding(s) in Company
28th May 20208:27 amRNSHolding(s) in Company
27th May 20205:09 pmRNSHolding(s) in Company
22nd May 20207:00 amRNSPerformance Update
21st May 202011:50 amRNSHolding(s) in Company
12th May 20204:40 pmRNSSecond Price Monitoring Extn
12th May 20204:35 pmRNSPrice Monitoring Extension
7th May 20207:00 amRNSHolding(s) in Company
6th May 20205:53 pmEQSForm 8.3 - Proactis Holdings Plc
6th May 20203:42 pmEQSForm 8.3 - Proactis Holdings Plc
6th May 202011:00 amRNSPrice Monitoring Extension
30th Apr 20201:35 pmRNSDirector/PDMR Shareholding
29th Apr 20207:00 amRNSInterim Results
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
28th Apr 20209:05 amRNSSecond Price Monitoring Extn
28th Apr 20209:00 amRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSReset of bank facilities
20th Apr 20207:00 amRNSCOVID-19 Update & Notice of Results
8th Apr 202010:57 amRNSHolding(s) in Company
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.